Erythropoietin receptors on cancer cells: a still open question [1]

Journal of Clinical Oncology

Volumn 25, Issue 13, 2007, Pages 1812-

  Ragione, Fulvio Della ^a   Cucciolla, Valeria ^a   Borriello, Adriana ^a   Oliva, Adriana ^a   Perrotta, Silverio ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; ERYTHROPOIETIN RECEPTOR; HEAT SHOCK PROTEIN 70; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CANCER CELL; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CELL STRAIN K 562; HEAD AND NECK CANCER; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LETTER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

CELL LINE, TUMOR; HUMANS; NEOPLASMS; RECEPTORS, ERYTHROPOIETIN;

EID: 34249039234     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.7212     Document Type: Letter

References (5)

1. Henke M, Mattern D, Pepe M, et al: Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J Clin Oncol 24:4708-4713, 2006
2. Elliott S, Busse L, Bass MB, et al: Anti-Epo receptor antibodies do not predict Epo receptor expression. Blood 107:1892-1895, 2006
3. Chin K, Oda N, Shen K, et al: Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs. Nucleic Acids Res 23:3041-3049, 1995
4. Ciocca DR, Calderwood SK: Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86-103, 2005
5. Della Ragione F, Cucciolla V, Criniti V, et al: p21Cip1 gene expression is modulated by Egr1: A novel regulatory mechanism involved in the resveratrol antiproliferative effect. J Biol Chem 178:23360-22368, 2003